Log in
Enquire now
‌

US Patent 7285417 Reference control containing a nucleated red blood cell component

Patent 7285417 was granted and assigned to Beckman Coulter on October, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent

Patent attributes

Current Assignee
Beckman Coulter
Beckman Coulter
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7285417
Patent Inventor Names
Nery Ortiz5
Sandra Socarras5
Date of Patent
October 23, 2007
Patent Application Number
11554098
Date Filed
October 30, 2006
Patent Citations Received
‌
US Patent 12023178 Method of detecting sepsis using vital signs, including systolic blood pressure, hematology parameters, and combinations thereof
1
‌
US Patent 11994514 Method of determining sepsis in the presence of blast flagging
2
‌
US Patent 11791022 Cross discipline disease management system
‌
US Patent 11852640 Hematology analyzers and methods of operation
3
‌
US Patent 12062448 Infection detection and differentiation systems and methods
4
Patent Primary Examiner
‌
Maureen M. Wallenhorst
Patent abstract

A method of making a reference control containing a nucleated red blood cell component includes providing a blood cell containing a nucleus; treating the blood cell with a treatment solution to alter a nucleus property from a natural value to a target value suitable for simulating nucleated red blood cells on a blood analyzer; and suspending treated blood cell in a suspension medium to form a reference control. The method also includes integrating the nucleated red blood cell component with white blood cell, red blood cell, platelet and reticulocyte components. Further disclosed is a cell treatment composition for altering a nucleus property, which includes a conditioning component, a lytic component for permeating cell membrane, and a fixing component for preserving the cell nucleus. Also disclosed is a method of using the reference control for measurement of nucleated red blood cells on a blood analyzer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7285417 Reference control containing a nucleated red blood cell component

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.